Saturday
,
July
31
,
2010
TEXT_SIZE
Home
Our Products
HIV / AIDS
Malaria
RSV
Influenza
Herpes Simplex
Virosome
Our Company
Management Strategy
Corporate Profile
Management Profiles
Jacques-François Martin
Ernest Luebke
Ronald Kempers
Dr. Sylvain Fleury
Dr. Toon Stegmann
Scientific Advisory Board
Dr. Stanley A. Plotkin
Dr. Marc Girard
Dr. Morgane Bomsel
Dr. Ronald H. Gray
Dr. M. William Makgoba
Dr. Soulemane Mboup
Dr. Juliana McElrath
Dr. Odile Puijalon
Dr. Caetano Reis e Sousa
Dr. Ruth Ruprecht
Key Partners
Investor Relations
Investor Relations Contacts
Press Releases
Industry Press Articles
Filings
Contact us
Display #
5
10
15
20
25
30
50
100
All
#
Web Link
1
Daily Finance - 29.04.2010 Dendreon's Prostate Cancer Vaccine Approved, and Its Shares Soar 27%
2
FT - 08.03.2010 AstraZeneca job cuts reflect new landscape
3
NYT - 09.03.2010 Counting on Clicks to Finance the Battle Against AIDS, Malaria and Tuberculosis
4
29.01.10 Gates Foundation pledges $10 Billion for Vaccines
5
17.11.09 Vaccines on horizon for AIDS, Alzheimer's, herpes
6
Times Live - 19.10.09 Aids Vaccine Conference Opens in Paris
7
WSJ - 10.10.09 Results of US Army/Thailand HIV Study called into question...full details of trial to be aired at Paris conference.
8
DN - 10.10.09 US Grants Kenya Sh200m to fight malaria
9
WSJ - 30.09.09 Sanofi CEO Still Shopping for Vaccine Companies to expand vaccine business
10
NYT - 30.09.09 U.N. Cites Global Rise in Detection and Treatment of AIDS
11
FT - 29.09.09 Vaccines give a boost to pharma M&A - vaccines are the new M&A targets
12
28.09.09 - Abbott Labs to acquire Solvay Group including Solvay's vaccine business
13
BBC - 23.09.09 Africa leaders unite on malaria
Sitemap
Privacy policy
Legal notice
TOP
© COPYRIGHT Mymetics 2009